评估340B关于在慢性阻塞性肺病中医疗保健使用的处方辅助计划
Leah M Taliaferro1, Sarah Dodson2, Melissa C Norton1
1Ascension Via Christi Hospitals Wichita, Inc., 929 N Saint Francis, Wichita, KS 67214, United States.
Exploratory research in clinical and social pharmacy
|July 5, 2023
概括
340B处方辅助计划 (PAP) 显著减少了COPD患者的住院和急诊室访问. 这种获得低成本药物的机会改善了医疗保健的利用率,并降低了患者的成本.
科学领域:
- 健康研究成果研究结果
- 卫生经济学 卫生经济学
- 肺部医学 肺部医学
背景情况:
- 联邦340B药物计划旨在扩大对综合患者服务的资源.
- 340B处方辅助计划 (PAP) 为符合条件的患者提供以降低成本获得药物.
研究的目的:
- 评估340B PAP对慢性阻塞性肺病 (COPD) 患者住院和急诊室访问的影响.
- 评估340亿PAP用于COPD患者的财务影响.
主要方法:
- 一个回顾性,前后队列研究115名COPD患者使用340B PAP用于吸入器/雾化器处方.
- 研究人员比较了PAP处方开始前后一年的数据.
- 威尔科克森签名等级测试分析了住院,急诊室访问和成本的变化.
主要成果:
- 综合平均所有原因住院和急诊室访问的显著减少 (2.42至1.66,p=0.002).
- 由于医疗保健利用率下降,估计每名患者平均避免成本为1012.82美元.
- 总的年度计划范围内的处方费用节省为患者178,050.21美元.
结论:
- 通过340B药物定价计划降低成本的药物与COPD患者的住院和ED访问减少有关.
- 340B PAP有效地减少了这种患者群体的医疗保健资源利用率.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
COPD: Management Using Bronchodilators and Corticosteroids
250
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
250
Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.0K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K


